×
About 10,030 results

ALLMedicine™ Deep Vein Thrombosis Center

Research & Reviews  3,244 results

A 40-Year-Old Man with Sarcoidosis and Factor V Leiden Thrombophilia Presenting with De...
https://doi.org/10.12659/AJCR.932286
The American Journal of Case Reports; Goljan-Geremek A, Puścińska E et. al.

Jul 31st, 2021 - BACKGROUND The association between sarcoidosis and pulmonary embolism (PE) has been described in the literature, but little is known about the origin of hypercoagulability and hypofibrinolysis in sarcoidosis. PE is a multifactorial disease that is...

Construction and Validation of a Nomogram for Predicting the Risk of Deep Vein Thrombos...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312330
Journal of Hepatocellular Carcinoma; Chen Y, Zhao J et. al.

Jul 30th, 2021 - The incidence of deep vein thrombosis (DVT) in hepatocellular carcinoma (HCC) patients after laparoscopic hepatectomy (LH) is unclear, and there is no effective method for DVT risk assessment in these patients. The data from the total of 355 conse...

The Perioperative Deep Vein Thrombosis in Lower Extremities in Patients With Pelvic Fra...
https://doi.org/10.1177/10760296211033024
Clinical and Applied Thrombosis/hemostasis : Official Jou... Yan Y, Zhang B et. al.

Jul 27th, 2021 - This study was to investigate the incidences of DVT in lower extremities after pelvic fracture before and after operation, and explore the risk factors. The records of patients with pelvic fractures receiving operation were collected. The patients...

Deep vein thrombosis of upper extremities in the era of direct Oral anticoagulants.
https://doi.org/10.1016/j.ijcard.2021.07.039
International Journal of Cardiology; Yamashita Y

Jul 25th, 2021 - Deep vein thrombosis of upper extremities in the era of direct Oral anticoagulants.|2021|Yamashita Y,|

see more →

Guidelines  12 results

American Society of Hematology 2020 guidelines for management of venous thromboembolism...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556153
Blood Advances; Ortel TL, Neumann I et. al.

Oct 3rd, 2020 - Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), occurs in ∼1 to 2 individuals per 1000 each year, corresponding to ∼300 000 to 600 000 events in the United States annually. These evidence-based ...

ACR Appropriateness Criteria® Radiologic Management of Iliofemoral Venous Thrombosis.
https://doi.org/10.1016/j.jacr.2020.01.035
Journal of the American College of Radiology : JACR; , Farsad K et. al.

May 7th, 2020 - Iliofemoral venous thrombosis carries a high risk for pulmonary embolism, recurrent deep vein thrombosis, and post-thrombotic syndrome complicating 30% to 71% of those affected. The clinical scenarios in which iliofemoral venous thrombosis is mana...

ACR Appropriateness Criteria® Suspected Upper Extremity Deep Vein Thrombosis.
https://doi.org/10.1016/j.jacr.2020.01.020
Journal of the American College of Radiology : JACR; , Desjardins B et. al.

May 7th, 2020 - This publication includes the appropriate imaging modalities to assess suspected deep vein thrombosis in the upper extremities. Ultrasound duplex Doppler is the most appropriate imaging modality to assess upper-extremity deep vein thrombosis. It i...

ACR Appropriateness Criteria® Radiologic Management of Venous Thromboembolism-Inferior ...
https://doi.org/10.1016/j.jacr.2019.02.010
Journal of the American College of Radiology : JACR; , Minocha J et. al.

May 6th, 2019 - Venous thromboembolism (VTE)-deep vein thrombosis and pulmonary embolism-is a common cause of morbidity and mortality. The mainstay of VTE prophylaxis and therapy is anticoagulation. In select patients with VTE, inferior vena cava (IVC) filters ar...

ACR Appropriateness Criteria® Suspected Lower Extremity Deep Vein Thrombosis.
https://doi.org/10.1016/j.jacr.2018.09.028
Journal of the American College of Radiology : JACR; , Hanley M et. al.

Nov 6th, 2018 - Suspected lower extremity deep venous thrombosis is a common clinical scenario which providers seek a reliable test to guide management. The importance of confidently making this diagnosis lies in the 50% to 60% risk of pulmonary embolism with unt...

see more →

Drugs  68 results see all →

Clinicaltrials.gov  147 results

Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
https://clinicaltrials.gov/ct2/show/NCT02507180

Feb 27th, 2020 - VTE is a leading cause of maternal death in the developed world. Suspected DVT in pregnancy is a common clinical problem faced by clinicians daily. The only validated method to exclude DVT in pregnancy requires leg vein CUS imaging. This imaging m...

Nestle Impact Advanced Recovery in Improving Surgery Recovery in Patients With Head and Neck Cancer
https://clinicaltrials.gov/ct2/show/NCT03261180

Feb 25th, 2020 - PRIMARY OBJECTIVES: I. Assess the effect of perioperative use of Nestle Impact Advanced Recovery (AR) on the rate of post-operative wound complications within 30 days after major head and neck surgery. SECONDARY OBJECTIVES: I. Assess whether sarco...

Low Molecular Weight Heparin (LMWH) vs Aspirin for Venous Thromboembolism (VTE) Prophylaxis in Orthopaedic Oncology
https://clinicaltrials.gov/ct2/show/NCT03244020

Feb 17th, 2020 - Lower extremity orthopaedic surgery and malignancy are both known major risk factors for venous thromboembolism (VTE). Guidelines from high quality data exist with regards to VTE prophylaxis in patients undergoing orthopaedic surgery, particularly...

Safety and Efficacy Study of Fitaya Vena Cava Filter
https://clinicaltrials.gov/ct2/show/NCT03691753

Feb 17th, 2020 - The trial was mainly for patients with high-risk deep vein thrombosis, and all subjects who passed the screening and signed the informed consent will be enrolled and be randomly divided into the experimental group and the control group according t...

Apixaban for Extended Anticoagulation (APIDULCIS)
https://clinicaltrials.gov/ct2/show/NCT03678506

Feb 5th, 2020 - This prospective cohort study aims to assess the efficacy and safety of a management procedure to decide on giving or not an extended anticoagulation (administering apixaban 2 2.5 mg twice daily ) to outpatients with a single episode of proximal d...

see more →

News  522 results

Latest Trends in the Management of Pulmonary Embolism
https://www.medscape.com/viewarticle/950894

May 11th, 2021 - One of the newest trends in pulmonary embolism management is treatment of cancer associated venous thromboembolism (VTE) which encompasses deep vein thrombosis (DVT) and PE. Following the clinical management of cancer-associated venous thromboembo...

Managing Diffuse Peripheral Ischemia in Antiphospholipid Syndrome: Anticoagulation, Immunosuppression, or Vasodilation?
https://www.medscape.com/viewarticle/948988

Apr 14th, 2021 - This article originally appeared on Hospital for Special Surgery's website. Case Report A 39-year-old man with a history of well-controlled type 1 diabetes (T1D) since childhood and migraine presented with 1 week of pain and cyanosis of the finger...

Managing Diffuse Peripheral Ischemia in Antiphospholipid Syndrome: Anticoagulation, Immunosuppression, or Vasodilation?
https://www.medscape.com/viewarticle/948988?src=sapfe

Apr 14th, 2021 - This article originally appeared on Hospital for Special Surgery's website. Case Report A 39-year-old man with a history of well-controlled type 1 diabetes (T1D) since childhood and migraine presented with 1 week of pain and cyanosis of the finger...

Denmark, Norway, and Iceland Suspend AstraZeneca COVID Shots After Blood Clot Reports
https://www.medscape.com/viewarticle/947300

Mar 12th, 2021 - COPENHAGEN (Reuters) - Health authorities in Denmark, Norway and Iceland on Thursday suspended the use of AstraZeneca's COVID-19 vaccine shots following reports of the formation of blood clots in some people who had been vaccinated. Austria earlie...

Apotex Corp. Issues Voluntary Nationwide Recall of Enoxaparin Sodium Injection, USP Due to Mislabeling of Syringe Barrel Measurement Markings | FDA
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/apotex-corp-issues-voluntary-nationwide-recall-enoxaparin-sodium-injection-usp-due-mislabeling

Summary Company Announcement Date: February 02, 2021 FDA Publish Date: February 03, 2021 Product Type: Drugs Reason for Announcement: Recall Reason Description Packaging error resulting in incorrect dosage listed Company Name: Apotex Corp Brand Na...

see more →

Patient Education  19 results see all →